251 related articles for article (PubMed ID: 12057669)
1. Chalcones and flavonoids as anti-tuberculosis agents.
Lin YM; Zhou Y; Flavin MT; Zhou LM; Nie W; Chen FC
Bioorg Med Chem; 2002 Aug; 10(8):2795-802. PubMed ID: 12057669
[TBL] [Abstract][Full Text] [Related]
2. Ring substituted 3-phenyl-1-(2-pyrazinyl)-2-propen-1-ones as potential photosynthesis-inhibiting, antifungal and antimycobacterial agents.
Opletalová V; Hartl J; Patel A; Palát K; Buchta V
Farmaco; 2002 Feb; 57(2):135-44. PubMed ID: 11902656
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic correlation of structurally modified chalcone derivatives as promising leads to treat tuberculosis.
Sabarathinam S; Ganamurali N; Satheesh S; Dhanasekaran D; Raja A
Future Med Chem; 2023 Oct; 15(20):1903-1913. PubMed ID: 37877262
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel furan-based chalcone derivatives as anti-tuberculosis agents:
Dhivya LS; Kumaradoss KM
Future Med Chem; 2023 Sep; 15(18):1687-1701. PubMed ID: 37732414
[No Abstract] [Full Text] [Related]
5. Novel aryloxy azolyl chalcones with potent activity against Mycobacterium tuberculosis H37Rv.
Marrapu VK; Chaturvedi V; Singh S; Singh S; Sinha S; Bhandari K
Eur J Med Chem; 2011 Sep; 46(9):4302-10. PubMed ID: 21764184
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3-Triazoles: A Computational Docking Techniques.
Sadineni K; Reddy Basireddy S; Rao Allaka T; Yatam S; Bhoomandla S; Muvvala V; Babu Haridasyam S
Chem Biodivers; 2024 May; 21(5):e202400389. PubMed ID: 38457745
[TBL] [Abstract][Full Text] [Related]
7. Biflavonoids as novel antituberculosis agents.
Lin YM; Flavin MT; Cassidy CS; Mar A; Chen FC
Bioorg Med Chem Lett; 2001 Aug; 11(16):2101-4. PubMed ID: 11514148
[TBL] [Abstract][Full Text] [Related]
8. QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity.
Gomes MN; Braga RC; Grzelak EM; Neves BJ; Muratov E; Ma R; Klein LL; Cho S; Oliveira GR; Franzblau SG; Andrade CH
Eur J Med Chem; 2017 Sep; 137():126-138. PubMed ID: 28582669
[TBL] [Abstract][Full Text] [Related]
9. Syntheses of lipophilic chalcones and their conformationally restricted analogues as antitubercular agents.
Ahmad I; Thakur JP; Chanda D; Saikia D; Khan F; Dixit S; Kumar A; Konwar R; Negi AS; Gupta A
Bioorg Med Chem Lett; 2013 Mar; 23(5):1322-5. PubMed ID: 23369537
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and
Dhivya LS; Pradeepa BR; Sarvesh S
Future Med Chem; 2022 Jun; 14(12):851-866. PubMed ID: 35548879
[No Abstract] [Full Text] [Related]
11. Design of potent fluoro-substituted chalcones as antimicrobial agents.
Burmaoglu S; Algul O; Gobek A; Aktas Anil D; Ulger M; Erturk BG; Kaplan E; Dogen A; Aslan G
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):490-495. PubMed ID: 28118738
[TBL] [Abstract][Full Text] [Related]
12. Bioactive flavonoids of the flowers of Butea monosperma.
Chokchaisiri R; Suaisom C; Sriphota S; Chindaduang A; Chuprajob T; Suksamrarn A
Chem Pharm Bull (Tokyo); 2009 Apr; 57(4):428-32. PubMed ID: 19336944
[TBL] [Abstract][Full Text] [Related]
13. New chalcone-sulfonamide hybrids exhibiting anticancer and antituberculosis activity.
Castaño LF; Cuartas V; Bernal A; Insuasty A; Guzman J; Vidal O; Rubio V; Puerto G; Lukáč P; Vimberg V; Balíková-Novtoná G; Vannucci L; Janata J; Quiroga J; Abonia R; Nogueras M; Cobo J; Insuasty B
Eur J Med Chem; 2019 Aug; 176():50-60. PubMed ID: 31096118
[TBL] [Abstract][Full Text] [Related]
14. Indole chalcones: Design, synthesis, in vitro and in silico evaluation against Mycobacterium tuberculosis.
Ramesh D; Joji A; Vijayakumar BG; Sethumadhavan A; Mani M; Kannan T
Eur J Med Chem; 2020 Jul; 198():112358. PubMed ID: 32361610
[TBL] [Abstract][Full Text] [Related]
15. Antimutagenic effects of flavonoids, chalcones and structurally related compounds on the activity of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and other heterocyclic amine mutagens from cooked food.
Edenharder R; von Petersdorff I; Rauscher R
Mutat Res; 1993 Jun; 287(2):261-74. PubMed ID: 7685486
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Synthetic Chemistry of Phenyl-3-(5-aryl-2-furyl)- 2-propen-1-ones as Urease Inhibitors: Mechanistic Approach through Urease Inhibition, Molecular Docking and Structure-Activity Relationship.
Fatima M; Aslam S; Zafar AM; Irfan A; Khan MA; Ashraf M; Faisal S; Noreen S; Shazly GA; Shah BR; Bin Jardan YA
Biomedicines; 2023 Aug; 11(9):. PubMed ID: 37760869
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitubercular activity of substituted novel pyrazoline derivatives.
Ali MA; Yar MS; Kumar M; Pandian GS
Nat Prod Res; 2007 Jun; 21(7):575-9. PubMed ID: 17613813
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in-vitro antimycobacterial activity of amino-5-[(substituted) phenyl]-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolylmethanethione.
Ali MA; Yar MS; Siddiqui AA; Husain A; Abdullah M
Acta Pol Pharm; 2007; 64(5):435-9. PubMed ID: 18540164
[TBL] [Abstract][Full Text] [Related]
19. QSAR studies on chalcones and flavonoids as anti-tuberculosis agents using genetic function approximation (GFA) method.
Sivakumar PM; Geetha Babu SK; Mukesh D
Chem Pharm Bull (Tokyo); 2007 Jan; 55(1):44-9. PubMed ID: 17202700
[TBL] [Abstract][Full Text] [Related]
20. Anti-tuberculosis evaluation and conformational study of N-acylhydrazones containing the thiophene nucleus.
Cardoso LN; Bispo ML; Kaiser CR; Wardell JL; Wardell SM; Lourenço MC; Bezerra FA; Soares RP; Rocha MN; de Souza MV
Arch Pharm (Weinheim); 2014 Jun; 347(6):432-48. PubMed ID: 24616002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]